Literature DB >> 8054493

The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia.

E L Teng1, K Hasegawa, A Homma, Y Imai, E Larson, A Graves, K Sugimoto, T Yamaguchi, H Sasaki, D Chiu.   

Abstract

The Cognitive Abilities Screening Instrument (CASI) has a score range of 0 to 100 and provides quantitative assessment on attention, concentration, orientation, short-term memory, long-term memory, language abilities, visual construction, list-generating fluency, abstraction, and judgment. Scores of the Mini-Mental State Examination, the Modified Mini-Mental State Test, and the Hasegawa Dementia Screening Scale can also be estimated from subsets of the CASI items. Pilot testing conducted in Japan and in the United States has demonstrated its cross-cultural applicability and its usefulness in screening for dementia, in monitoring disease progression, and in providing profiles of cognitive impairment. Typical administration time is 15 to 20 minutes. Record form, manual, videotape of test administration, and quizzes to qualify potential users on the administration and scoring of the CASI are available upon request.

Entities:  

Mesh:

Year:  1994        PMID: 8054493     DOI: 10.1017/s1041610294001602

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  271 in total

1.  A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging Study.

Authors:  D J Galanis; C Joseph; K H Masaki; H Petrovitch; G W Ross; L White
Journal:  Am J Public Health       Date:  2000-08       Impact factor: 9.308

2.  Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study.

Authors:  Lenore J Launer; Timothy M Hughes; Lon R White
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

3.  Age-varying association between statin use and incident Alzheimer's disease.

Authors:  Ge Li; Jane B Shofer; Isaac C Rhew; Walter A Kukull; Elaine R Peskind; Wayne McCormick; James D Bowen; Gerard D Schellenberg; Paul K Crane; John C S Breitner; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2010-06-01       Impact factor: 5.562

4.  Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments.

Authors:  Carrie B Peltz; María M Corrada; Daniel J Berlau; Claudia H Kawas
Journal:  Neurology       Date:  2011-11-09       Impact factor: 9.910

Review 5.  [Arterial hypertension and dementia].

Authors:  R Scheid; H Voigt
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

6.  Effect of Bcl-2 rs956572 SNP on regional gray matter volumes and cognitive function in elderly males without dementia.

Authors:  Mu-En Liu; Chu-Chung Huang; Jen-Ping Hwang; Albert C Yang; Pei-Chi Tu; Heng-Liang Yeh; Chen-Jee Hong; Ying-Jay Liou; Jin-Fan Chen; Ching-Po Lin; Shih-Jen Tsai
Journal:  Age (Dordr)       Date:  2011-12-25

7.  Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.

Authors:  Luis D Medina; Yaneth Rodriguez-Agudelo; Daniel H Geschwind; Paul E Gilbert; Li-Jung Liang; Jeffrey L Cummings; John M Ringman
Journal:  Dement Geriatr Cogn Disord       Date:  2011-08-30       Impact factor: 2.959

8.  GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.

Authors:  Debby Tsuang; James B Leverenz; Oscar L Lopez; Ronald L Hamilton; David A Bennett; Julie A Schneider; Aron S Buchman; Eric B Larson; Paul K Crane; Jeffrey A Kaye; Patricia Kramer; Randy Woltjer; Walter Kukull; Peter T Nelson; Gregory A Jicha; Janna H Neltner; Doug Galasko; Eliezer Masliah; John Q Trojanowski; Gerard D Schellenberg; Dora Yearout; Haley Huston; Allison Fritts-Penniman; Ignacio F Mata; Jia Y Wan; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian
Journal:  Neurology       Date:  2012-10-03       Impact factor: 9.910

9.  Adjustment for selection bias in observational studies with application to the analysis of autopsy data.

Authors:  S Haneuse; J Schildcrout; P Crane; J Sonnen; J Breitner; E Larson
Journal:  Neuroepidemiology       Date:  2009-01-29       Impact factor: 3.282

10.  Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.

Authors:  Margaret C Fang; Praveen Panguluri; Edward L Machtinger; Dean Schillinger
Journal:  Patient Educ Couns       Date:  2009-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.